Press Releases

PetMedix win Best Start-up 2019 in the Animal Pharm Awards

PetMedix has been voted best start-up in the global Animal Pharm Awards. The UK-based start-up is developing a new tier of monoclonal antibody therapy for the animal health market. Situated in the heart of the Cambridge biotechnology cluster, 2020 will see the company take up residence in the new Babraham Campus later in the year.

Read More »

PetMedix announces £8M Series A funding

PetMedix is applying 30 years of antibody research and the scientific work of two of its founders, Professor Allan Bradley FRS and Dr Jolyon Martin, to develop new pet therapeutics against a wide range of diseases. Led by founder and CEO, Dr Tom Weaver, PetMedix has recently raised £8 million in Series A funding and will use this to establish operations, grow the team, continue to build the platforms, and begin drug discovery. The investment was led by Digitalis Ventures (NYC) with Parkwalk Advisors (London) as their syndicate partner.

Read More »
Scroll to Top